Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Acerbi

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Respiratory Medicine|February 21, 2003
Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteersG Poli, D Acerbi
The American Journal of Cardiology|June 16, 1995
Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitorR Razzetti, D Acerbi
Pulmonary Pharmacology & Therapeutics|August 8, 2006
Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technologyD Acerbi, G Brambilla, I Kottakis
Agents and Actions|February 1, 1984
A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate)P Schiantarelli, S Cadel, D Acerbi
Respiratory Medicine|August 31, 2002
Modulite technology: pharmacodynamic and pharmacokinetic implicationsA Woodcock, D Acerbi, G Poli
International Journal of Clinical Pharmacology Research|January 1, 1991
Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failureI Rondelli, D Acerbi, P Ventura
Arzneimittel-Forschung|January 1, 1981
Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in manP Schiantarelli, D Acerbi, G Bovis
European Journal of Drug Metabolism and Pharmacokinetics|September 2, 1998
Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemesD Acerbi, G Poli, P Ventura
European Journal of Rheumatology and Inflammation|January 1, 1993
Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animalsR E Lister, D Acerbi, S Cadel
Arzneimittel-Forschung|January 1, 1982
Antiinflammatory activity and bioavailability of percutaneous piroxicamP Schiantarelli, S Cadel, D Acerbi, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Respiratory Medicine|February 21, 2003
Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteersG Poli, D Acerbi
The American Journal of Cardiology|June 16, 1995
Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitorR Razzetti, D Acerbi
Pulmonary Pharmacology & Therapeutics|August 8, 2006
Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technologyD Acerbi, G Brambilla, I Kottakis
Agents and Actions|February 1, 1984
A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate)P Schiantarelli, S Cadel, D Acerbi
Respiratory Medicine|August 31, 2002
Modulite technology: pharmacodynamic and pharmacokinetic implicationsA Woodcock, D Acerbi, G Poli
International Journal of Clinical Pharmacology Research|January 1, 1991
Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failureI Rondelli, D Acerbi, P Ventura
Arzneimittel-Forschung|January 1, 1981
Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in manP Schiantarelli, D Acerbi, G Bovis
European Journal of Drug Metabolism and Pharmacokinetics|September 2, 1998
Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemesD Acerbi, G Poli, P Ventura
European Journal of Rheumatology and Inflammation|January 1, 1993
Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animalsR E Lister, D Acerbi, S Cadel
Arzneimittel-Forschung|January 1, 1982
Antiinflammatory activity and bioavailability of percutaneous piroxicamP Schiantarelli, S Cadel, D Acerbi, et al.
Pageof 4